April 28, 2025 Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors Aya Ozaki and others
April 28, 2025 Balancing the Risk of Cardiotoxicity Outcomes in Treatment Selection for Multiple Myeloma: A Retrospective Multicenter Evaluation of Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Aya Ozaki and others
March 5, 2025 Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy Aya Ozaki and others
February 3, 2025 Racial Disparities in Mood Stabilizer Prescribing in Mania in Nonpsychotic, Hospitalized Patients With Bipolar I Disorder Farah Khorassani, Nana Entsuah-Boateng, Aya Ozaki and others
April 17, 2024 Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study Aya Ozaki and others
